Artiva Biotherapeutics, Inc. 10-Q filing
Filed 2025-08-06 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000950170-25-104045
- Form type
- 10-Q
- CIK
- 0001817241
- Primary document
- https://www.sec.gov/Archives/edgar/data/1817241/000095017025104045/artv-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Artiva Biotherapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $251,000 | - | - |
| Operating Income | $-45.0M | - | - |
| Net Income | $-41.6M | - | - |
| Eps Basic | -1.71 | - | - |
| Eps Diluted | -1.71 | - | - |
| Cash And Equivalents | $28.5M | - | - |
| Total Assets | $169.4M | - | - |
| Total Liabilities | $20.4M | - | - |
| Shareholders Equity | $149.0M | - | - |
| Operating Cash Flow | $-42.8M | - | - |
| Capital Expenditures | $1.6M | - | - |